Activation and inactivation of the FLT3 kinase: Pathway intermediates and the free energy of transition

G Todde, R Friedman - The Journal of Physical Chemistry B, 2019 - ACS Publications
… with previous estimates obtained for other kinases. Finally, we identified FLT3 intermediates
that assumed configurations that resemble that of the c-Src nonreceptor tyrosine kinase. The …

Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid …

H Janke, F Pastore, D Schumacher, T Herold… - PloS one, 2014 - journals.plos.org
… and signaling we analyzed eight different FLT3 mutations: Three different FLT3-ITD constructs,
FLT3-… FLT3-TKD mutants showed intermediate response , whereas no effect was seen in …

Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications

S Takahashi - Journal of hematology & oncology, 2011 - Springer
… (22.1%), and these mutations were highly enriched in a group of patients with an intermediate-risk
cytogenetic profile as well as FLT3 mutations (25 of 61 patients, 41.0%; P < 0.003) [6]. …

Mechanisms underlying resistance to FLT3 inhibitors in acute myeloid leukemia

M Eguchi, Y Minami, A Kuzume, SG Chi - Biomedicines, 2020 - mdpi.com
… Phosphorylated FLT3 activates multiple intracellular signaling pathwaysFLT3-ITD high
with wild type NPM1 and FLT3-ITD low with mutated NPM1 are classified as intermediate

Flt3 receptor tyrosine kinase as a drug target in leukemia

D Schmidt-Arras, J Schwable… - Current …, 2004 - ingentaconnect.com
… of Flt3 tyrosine kinase activity have the potential to suppress aberrant Flt3 signaling. … that
this form represents an intermediate form containing high-mannose Nlinked sugars [13, 14]. …

Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3

K Masson, L Rönnstrand - Cellular signalling, 2009 - Elsevier
… , but in the case of Flt3, the most common alterations … Flt3 signaling has also revealed the
complexity of these receptor systems. The impact of gain-of-function mutations of c-Kit and Flt3

Oncogenic protein tyrosine kinases: Normal and oncogenic FLT3

T Naoe, H Kiyoi - Cellular and Molecular Life Sciences CMLS, 2004 - Springer
… Since the DNA corresponding to D593 to K602 of FLT3 potentially forms a palindromic
intermediate, a hairpin formation of a lagging strand and replication slippage might generate ITD …

FLT3 mutations: biology and treatment

D Small - ASH Education Program Book, 2006 - ashpublications.org
… through phosphorylation downstream of FLT3 activation, as mentioned above. Specific …
FLT3 signaling. More work remains to elucidate the complete signaling pathway altered by FLT3

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond

SA Wander, MJ Levis, AT Fathi - Therapeutic advances in …, 2014 - journals.sagepub.com
… in the FLT3 receptor tyrosine kinaseFLT3 signaling in vivo. Here we will review results
from preclinical studies and early clinical trials evaluating both first- and second-generation FLT3

Targeting oncogenic signaling in mutant FLT3 acute myeloid leukemia: the path to least resistance

D Staudt, HC Murray, T McLachlan, F Alvaro… - International journal of …, 2018 - mdpi.com
… For intermediate and poor prognosis patients (including FLT3 mutant patients) that achieve
complete remission (CR), allogeneic hematopoietic stem cell transplant (alloHSCT) leads to …